My name is Philippos Peidis and I am from Thessaloniki, Greece. For my doctoral thesis I studied non-conventional functions of a group of kinases called SRPKs. After completing my PhD, I spent 4 years in Montreal researching the effects of eIF2alpha kinases on the response to chemotherapeutic drugs. In my current position I am very enthusiastic about exploring signaling pathways and mechanisms of resistance to targeted therapies in cancer, and especially in RET-altered malignancies.